Document is current
Any future updates will be listed below
-
Authors
Dippon, Vanessa N. https://orcid.org/0009-0009-8434-732X
Rizvi, Zeba https://orcid.org/0000-0002-3510-4454
Choudhry, Anthony E.
Chung, Chun-wa https://orcid.org/0000-0002-2480-3110
Alkuraya, Ibrahim F.
Xu, Wenqing https://orcid.org/0000-0001-7385-3141
Tao, Xavier B. https://orcid.org/0009-0003-0964-2296
Jurewicz, Anthony J.
Schneck, Jessica L. https://orcid.org/0009-0007-2312-825X
Chen, Wenqian
Curnutt, Nicole M. https://orcid.org/0000-0003-3194-906X
Kabir, Farah
Chan, Kwok-Ho https://orcid.org/0000-0002-6693-2682
Queisser, Markus A. https://orcid.org/0000-0002-3368-3827
Musetti, Caterina
Dai, Han
Lander, Gabriel C. https://orcid.org/0000-0003-4921-1135
Benowitz, Andrew B. https://orcid.org/0000-0002-9913-605X
Woo, Christina M. https://orcid.org/0000-0001-8687-9105
- License Information
-
More Information
Article History
Received: 12 August 2024
Accepted: 2 December 2025
First Online: 21 January 2026
Competing interests
: The Woo laboratory receives or has received support from Amgen, Ono Pharmaceuticals and Merck. A.E.C., C.-w.C., A.J.J., J.L.S., K.-H.C., M.A.Q., C.M., H.D. and A.B.B. are/were employees and/or shareholders of GSK. The other authors declare no competing interests.
